IN2012DN00338A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00338A IN2012DN00338A IN338DEN2012A IN2012DN00338A IN 2012DN00338 A IN2012DN00338 A IN 2012DN00338A IN 338DEN2012 A IN338DEN2012 A IN 338DEN2012A IN 2012DN00338 A IN2012DN00338 A IN 2012DN00338A
- Authority
- IN
- India
- Prior art keywords
- methods
- relates
- present
- region containing
- containing protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
The present invention relates, at least in part, to improved methods of protein purification. In particular, the present invention relates, at least in part, to methods for purifying an Fc region containing protein from a composition comprising the Fc region containing protein and one or more impurities, where the methods eliminate the need for a holding tank and/or a buffer exchange step.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27370909P | 2009-08-07 | 2009-08-07 | |
| PCT/US2010/044539 WO2011017514A1 (en) | 2009-08-07 | 2010-08-05 | Methods for purifying a target protein from one or more impurities in a sample |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN00338A true IN2012DN00338A (en) | 2015-05-22 |
Family
ID=43544660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN338DEN2012 IN2012DN00338A (en) | 2009-08-07 | 2010-08-05 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8536316B2 (en) |
| EP (1) | EP2462157B1 (en) |
| JP (2) | JP5791602B2 (en) |
| KR (1) | KR101415660B1 (en) |
| CN (2) | CN102574911B (en) |
| ES (1) | ES2817802T3 (en) |
| IN (1) | IN2012DN00338A (en) |
| SG (1) | SG177577A1 (en) |
| WO (1) | WO2011017514A1 (en) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3237179B2 (en) | 1992-03-18 | 2001-12-10 | 栗田工業株式会社 | Removal method of hydrogen peroxide from waste ultrapure water |
| WO2011090719A2 (en) * | 2009-12-29 | 2011-07-28 | Dr. Reddy's Laboratories Ltd. | Protein purification by ion exchange |
| HRP20171095T4 (en) | 2010-05-25 | 2022-07-22 | F. Hoffmann - La Roche Ag | Methods of purifying polypeptides |
| WO2012015908A2 (en) | 2010-07-30 | 2012-02-02 | Millipore Corporation | Chromatography media and method |
| RU2661764C2 (en) | 2011-05-27 | 2018-07-19 | Эббви Байотекнолоджи Лтд., | Compositions and methods based on dac hyp |
| EP2721052A1 (en) * | 2011-06-16 | 2014-04-23 | DSM IP Assets B.V. | Single unit chromatography antibody purification |
| JP6280499B2 (en) * | 2011-07-08 | 2018-02-14 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Purification method of FC fusion protein |
| CN103827134A (en) | 2011-07-20 | 2014-05-28 | 泽普泰恩股份有限公司 | Polypeptide separation methods |
| WO2013019889A2 (en) * | 2011-08-01 | 2013-02-07 | Avaxia Biologics, Inc. | Bovine polyclonal antibody specific for human tnf |
| US9096648B2 (en) | 2011-08-19 | 2015-08-04 | Emd Millipore Corporation | Methods of reducing level of one or more impurities in a sample during protein purification |
| WO2013033517A1 (en) * | 2011-09-01 | 2013-03-07 | Human Genome Sciences, Inc. | Viral clearance methods |
| EP2578286A1 (en) * | 2011-10-04 | 2013-04-10 | Merck Patent GmbH | Method and apparatus for chromatographic purification |
| KR20140091721A (en) * | 2011-11-02 | 2014-07-22 | 제넨테크, 인크. | Overload and elute chromatography |
| WO2013075740A1 (en) | 2011-11-23 | 2013-05-30 | Sanofi | Antibody purification method |
| CN102492040B (en) * | 2011-12-29 | 2014-06-25 | 嘉和生物药业有限公司 | Method for purifying anti-HER2 or/and anti-HER3 antibody proteins |
| SG10201701224UA (en) * | 2012-03-12 | 2017-04-27 | Merck Patent Gmbh | Removal of protein aggregates from biopharmaceutical preparations in a flowthrough mode |
| EP2682168A1 (en) | 2012-07-02 | 2014-01-08 | Millipore Corporation | Purification of biological molecules |
| EP2889617B1 (en) | 2012-08-27 | 2017-10-11 | Asahi Kasei Medical Co., Ltd. | Antibody purification method by means of temperature-responsive chromatography |
| KR102250937B1 (en) * | 2012-09-11 | 2021-05-12 | 코히러스 바이오사이언시즈, 인코포레이티드 | Correctly folded etanercept in high purity and excellent yield |
| MY178616A (en) | 2012-09-17 | 2020-10-19 | Grace W R & Co | Chromatography media and devices |
| US10421795B2 (en) | 2012-12-17 | 2019-09-24 | Merck Sharp & Dohme Corp. | Process for purifying insulin and analogues thereof |
| SI2959509T1 (en) | 2013-02-14 | 2018-11-30 | Nanopareil, Llc | Electrospun hybrid nanofibre felt, method for making the same, and method for purifying biomolecules |
| DK2994485T3 (en) * | 2013-05-06 | 2018-04-23 | Sanofi Sa | CONTINUOUS MULTIPLE STEP PROCEDURE FOR PURIFICATION OF ANTIBODIES |
| EP3041593B1 (en) * | 2013-09-05 | 2025-01-29 | F. Hoffmann-La Roche AG | Method of cleaning a chromatography material for its reuse |
| KR20160054597A (en) * | 2013-09-17 | 2016-05-16 | 가부시키가이샤 가네카 | Novel antibody purification method and antibody obtained therefrom, and novel antibody purification method using cation exchanger and antibody obtained therefrom |
| US9951101B2 (en) | 2013-12-12 | 2018-04-24 | Emd Millipore Corporation | Protein separations using an acrylamide containing filter |
| JP6612242B2 (en) * | 2014-02-14 | 2019-11-27 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | Automated multi-stage purification system and multi-stage chromatography purification method |
| EP3116891B1 (en) | 2014-03-10 | 2020-02-12 | Richter Gedeon Nyrt. | Immunoglobulin purification using pre-cleaning steps |
| CN104826617B (en) * | 2014-03-25 | 2017-06-13 | 西北大学 | Difunctional mixed mode chromatographic stationary phases of a kind of WAX/HIC for Separation of Proteins and preparation method thereof |
| JP6914189B2 (en) | 2014-05-02 | 2021-08-04 | ダブリュー・アール・グレース・アンド・カンパニー−コーンW R Grace & Co−Conn | Functionalized Carrier Materials and Methods for Making and Using Functionalized Carrier Materials |
| WO2015198320A1 (en) * | 2014-06-24 | 2015-12-30 | Insight Biopharmaceuticals Ltd. | Methods of purifying antibodies |
| DE102014010353B4 (en) | 2014-07-10 | 2024-09-12 | Sartorius Stedim Biotech Gmbh | Device, use of this device and method for substance separation with improved utilization of the capacity of chromatographic media |
| US20170298091A1 (en) | 2014-12-08 | 2017-10-19 | Emd Millipore Corporation | Mixed Bed Ion Exchange Adsorber |
| CN107921407B (en) | 2015-06-05 | 2022-07-05 | 格雷斯公司 | Biological treatment adsorption clarifying agent and preparation and use methods thereof |
| WO2017176735A1 (en) * | 2016-04-05 | 2017-10-12 | Haemonetics Corporation | Methods and devices for the enrichment of immunoglobulin from blood |
| CN107964044B (en) * | 2016-10-19 | 2021-11-19 | 无锡科捷诺生物科技有限责任公司 | Method for purifying anti-CD 20 monoclonal antibody from milk sample |
| US11155575B2 (en) | 2018-03-21 | 2021-10-26 | Waters Technologies Corporation | Non-antibody high-affinity-based sample preparation, sorbent, devices and methods |
| EP3546475A1 (en) | 2018-03-27 | 2019-10-02 | Sanofi | Full flow-through process for purifying recombinant proteins |
| US20210380638A1 (en) * | 2018-12-21 | 2021-12-09 | WuXi Biologics Ireland Limited | A method for improving aggregate removal by Protein A chromatography |
| FR3099066B1 (en) | 2019-07-26 | 2021-08-13 | Novasep Process | Purification process of a target substance with viral inactivation |
| TW202128264A (en) | 2019-09-25 | 2021-08-01 | 瑞士商赫孚孟拉羅股份公司 | Cation chromatography using predicted elution buffer salt concentration |
| WO2021064079A1 (en) * | 2019-10-04 | 2021-04-08 | Merck Patent Gmbh | Purification of proteins and viral inactivation |
| CN110724204B (en) * | 2019-11-18 | 2021-10-22 | 广东菲鹏制药股份有限公司 | Purification method of Fc fusion protein |
| CN113845562A (en) * | 2020-06-28 | 2021-12-28 | 佛山汉腾生物科技有限公司 | Method for purifying target protein |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4490937A (en) | 1981-12-07 | 1985-01-01 | Amcor Ltd. | Insect electrocution device |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5256694A (en) | 1984-09-22 | 1993-10-26 | Basf Aktiengesellschaft | Diarylacetylenes, their preparation and their use |
| US5091178A (en) | 1986-02-21 | 1992-02-25 | Oncogen | Tumor therapy with biologically active anti-tumor antibodies |
| US6054051A (en) | 1996-01-17 | 2000-04-25 | Genentech, Inc. | Tangential-flow filtration system |
| SI1501369T1 (en) | 2002-04-26 | 2015-10-30 | Genentech, Inc. | Non-affinity purification of proteins |
| CN100522989C (en) * | 2002-09-11 | 2009-08-05 | 中外制药株式会社 | Method of purifying protein |
| GB0304576D0 (en) * | 2003-02-28 | 2003-04-02 | Lonza Biologics Plc | Protein a chromatography |
| US20080312425A1 (en) * | 2004-08-30 | 2008-12-18 | Lonza Biologics Plc. | Ion Exchange Chromatography and Purification of Antibodies |
| EP2069387A4 (en) * | 2006-06-14 | 2011-02-02 | Glaxosmithkline Llc | Methods for purifying antibodies using ceramic hydroxyapatite |
| JP2010501623A (en) * | 2006-08-28 | 2010-01-21 | アレス トレーディング ソシエテ アノニム | Purification method of Fc-containing protein |
| KR20090058532A (en) | 2006-08-28 | 2009-06-09 | 아레스 트레이딩 에스.에이. | How to Purify FFC Fusion Proteins |
| JP2010516651A (en) * | 2007-01-17 | 2010-05-20 | メルク セローノ ソシエテ アノニム | Methods for purification of Fc-containing proteins |
| US9433922B2 (en) | 2007-08-14 | 2016-09-06 | Emd Millipore Corporation | Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same |
| WO2009045897A1 (en) * | 2007-10-03 | 2009-04-09 | Dyax Corp. | Systems and methods for purifying proteins |
| CN103396480A (en) | 2008-05-15 | 2013-11-20 | 诺沃—诺迪斯克有限公司 | Antibody purification process |
| CN104974251A (en) * | 2008-10-20 | 2015-10-14 | Abbvie公司 | Viral inactivation during purification of antibodies |
-
2010
- 2010-08-05 US US12/851,082 patent/US8536316B2/en not_active Expired - Fee Related
- 2010-08-05 CN CN201080035153.XA patent/CN102574911B/en not_active Expired - Fee Related
- 2010-08-05 CN CN201710418825.9A patent/CN107188960A/en active Pending
- 2010-08-05 JP JP2012523945A patent/JP5791602B2/en not_active Expired - Fee Related
- 2010-08-05 IN IN338DEN2012 patent/IN2012DN00338A/en unknown
- 2010-08-05 EP EP10807153.1A patent/EP2462157B1/en active Active
- 2010-08-05 WO PCT/US2010/044539 patent/WO2011017514A1/en not_active Ceased
- 2010-08-05 ES ES10807153T patent/ES2817802T3/en active Active
- 2010-08-05 KR KR1020127001161A patent/KR101415660B1/en not_active Expired - Fee Related
- 2010-08-05 SG SG2012001483A patent/SG177577A1/en unknown
-
2015
- 2015-05-01 JP JP2015093970A patent/JP6335838B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP2462157A4 (en) | 2012-12-26 |
| US20110065901A1 (en) | 2011-03-17 |
| KR101415660B1 (en) | 2014-07-16 |
| EP2462157A1 (en) | 2012-06-13 |
| EP2462157B1 (en) | 2020-06-17 |
| WO2011017514A1 (en) | 2011-02-10 |
| JP5791602B2 (en) | 2015-10-07 |
| ES2817802T3 (en) | 2021-04-08 |
| CN102574911A (en) | 2012-07-11 |
| US8536316B2 (en) | 2013-09-17 |
| JP2013501721A (en) | 2013-01-17 |
| SG177577A1 (en) | 2012-03-29 |
| KR20120089432A (en) | 2012-08-10 |
| JP6335838B2 (en) | 2018-05-30 |
| CN107188960A (en) | 2017-09-22 |
| JP2015157846A (en) | 2015-09-03 |
| CN102574911B (en) | 2017-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN00801A (en) | ||
| MX2009007632A (en) | Polyelectrolyte precipitation and purification of proteins. | |
| TW200801262A (en) | Method for purifying silicon | |
| MX336715B (en) | Purification of iduronate-2-sulfatase. | |
| MX2011008621A (en) | Process for purifying lipopeptides. | |
| BRPI0917993A2 (en) | Purified Mesenchymal Stem Cell Compositions and Methods of Purification of Purified Mesenchymal Stem Cell Compositions. | |
| PL2291329T3 (en) | Apparatus for purifying liquids, in particular ballast water | |
| HUE046909T2 (en) | Method for purifying recombinant adamts13 and other proteins and compositions thereof | |
| EA201070987A1 (en) | PURIFIED HYBRID PROTEINS OF IMMUNOGLOBULIN AND METHODS OF THEIR PURIFICATION | |
| MX2012004110A (en) | Process for purifying (hydro) fluoroalkenes. | |
| EA201270616A1 (en) | HEPATITIS C VIRUS INHIBITORS | |
| GB2471806A (en) | Compositions and methods for treating viral infections | |
| WO2010151797A3 (en) | Compounds for modulating rna binding proteins and uses therefor | |
| MX2012002565A (en) | Enhanced protein purification through a modified protein a elution. | |
| MX342920B (en) | Method for purifying active polypeptides or immunocojugates. | |
| MY188566A (en) | Method to improve virus removal in protein purification | |
| WO2011017132A3 (en) | Mk2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration | |
| UA108636C2 (en) | PEPTIDE | |
| WO2008085962A3 (en) | Cell culture methods for producing recombinant proteins in the presence of reduced levels of one or more contaminants | |
| EP2462157A4 (en) | Methods for purifying a target protein from one or more impurities in a sample | |
| MX2011000281A (en) | Recombinant fibrinogen. | |
| IN2012DN01849A (en) | ||
| MX2011008179A (en) | Peptides for vaccine. | |
| TW200738622A (en) | Process for purifying (meth)acrylates | |
| UA103197C2 (en) | Use of nifurtimox for the treatment of diseases caused by trichomonadida |